Matthew Stephen Young serves as Executive at Nutex Health, Inc., where they oversee executive responsibilities. Since joining the company, Matthew Stephen Young has executed 3 insider transactions totaling $367.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 13, 2022 involved selling 43,880 shares valued at $90.4K.
Matthew Stephen Young currently holds 41,964,832 shares of Nutex Health, Inc. (NUTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Stephen Young has been a net seller of NUTX stock. They have purchased $0 and sold $367.7K worth of shares.
Matthew Stephen Young's most recent insider trade was on Dec 13, 2022, when they sold 43,880 shares at $2.06 per share.
Get notified when new Form 4 filings are submitted
| $2.21 |
| Discretionary |
| Apr 1, 2022 | NUTX | $0 | Award | 42,134,210 | $N/A | Discretionary |